Asian American and Pacific Islander Month: Disparities in Melanoma Outcomes Between Asian Americans, Pacific Islanders, and White Patients
The month of May celebrated Asian American and Pacific Islander Heritage Month a period dedicated to the recognition of the contributions and influence of Asian Americans and Pacific Islander Americans to the history, culture, and achievements. In light of this observance, the subject of disparities in melanoma outcomes between patients of Asian American and Pacific Islander […]
Skin Cancer Awareness Month: Blood Pressure Medications May Increase Skin Cancer Risk
Skin cancer is a continuously increasing cancer in the United States despite improvements in treatment and survival outcomes. While UV radiation exposure is the most important environmental risk factor to control for in terms of skin cancer prevention, photo-toxicity induced by certain medications can worsen cellular damage to the skin and increase the sun’s carcinogenic […]
Skin Cancer Awareness Month: Assessing Cancer Risk Associated with Immunosuppressive TherapiesÂ
Over the past few decades, the dermatologic care of inflammatory skin conditions has been transformed through the growing use of small molecules disease-modifying anti-rheumatic drugs (DMARDs) and targeted biologic therapies. However, alongside the tremendous benefits offered by these therapeutic agents are concerns regarding potential adverse effects, in particular associated risks of cancer development. The controversial […]
Skin Cancer Awareness Month: AI Model Predicts Immunotherapy Response in Melanoma Patients
The discovery of immune checkpoint inhibitors (ICIs) revolutionized the treatment of advanced melanoma, however, there is currently no easy way to predict patient response  or their risk for immune-related toxicities without conducting RNA sequencing – a method rarely found at community oncology clinics. Researchers report an emerging technique that aims to solve this problem by […]
AI Model Predicts Immunotherapy Response in Melanoma Patients
The discovery of immune checkpoint inhibitors (ICIs) revolutionized the treatment of advanced melanoma, however, there is currently no easy way to predict patient response  or their risk for immune-related toxicities without conducting RNA sequencing – a method rarely found at community oncology clinics. Researchers report an emerging technique that aims to solve this problem by […]
Cutaneous Oncology in the Primary Care Setting
As one of the most common forms of cancer, skin cancer will affect up to 20% of the United States population over the course of a lifetime. Every day, nearly 10,000 people are diagnosed with skin cancer and more Americans are diagnosed with this condition than with all other cancers combined. Due to time and […]
Remembering Bob Marley: Rare Melanomas and Racial Disparities in Cutaneous OncologyÂ
Known as one of the pioneers of reggae who increased the visibility of Jamaican music across the globe, Bob Marley is less recognized for his battle with a rare form of melanoma – acral lentiginous melanoma. The story of the global pop culture figure highlights the racial disparities in prevalence and treatment of melanomas, as […]
Medicaid Expansion Promotes Early Skin Cancer DetectionÂ
Cancer remains as the second leading cause of death in the United States making early-stage diagnoses, which greatly improve patient survival rates, a key priority for public health. As cancer screenings can increase early detection it is important to address the lack of adequate insurance coverage and access to medical care that prevents many individuals […]
UV Safety Awareness Month: Essential Skin Protection Practices
The month of July is celebrated as UV Safety Awareness Month bringing attention to the many harmful effects of ultraviolet (UV) radiation exposure and underscoring the importance of sun-safe habits, skin protection, and other sun damage preventions strategies. With over 5 million cases of skin cancer diagnosed per year in the United States alone, skin […]
Cutaneous Cancer Metastases in Surgical Scar
Discovered in approximately 1.3% cases at the time of primary tumor presentation, cutaneous metastases of cancers are extremely rare. The phenomenon generally occurs several years after primary diagnosis or resection of the primary tumor, commonly secondary to malignant melanoma, cancer of the lung, or breast cancer. Cutaneous metastases occur in 4% to 6.5% of metastatic […]
